The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Luckily for you, we at StockStory have no conflicts of interest - our sole job is to help you find genuinely promising companies. Keeping that in mind, here is one stock likely to meet or exceed Wall Street’s lofty expectations and two where its enthusiasm might be excessive.
Two Stocks to Sell:
Hologic (HOLX)
Consensus Price Target: $68.56 (30% implied return)
As a pioneer in 3D mammography technology that has revolutionized breast cancer detection, Hologic (NASDAQ:HOLX) develops and manufactures diagnostic products, medical imaging systems, and surgical devices focused primarily on women's health and wellness.
Why Does HOLX Fall Short?
- Underwhelming constant currency revenue performance over the past two years suggests its product offering at current prices doesn’t resonate with customers
- Costs have risen faster than its revenue over the last five years, causing its adjusted operating margin to decline by 23.2 percentage points
- Waning returns on capital imply its previous profit engines are losing steam
Hologic is trading at $52.73 per share, or 11.9x forward P/E. If you’re considering HOLX for your portfolio, see our FREE research report to learn more.
BrightSpring Health Services (BTSG)
Consensus Price Target: $25.32 (20.6% implied return)
Founded in 1974, BrightSpring Health Services (NASDAQ:BTSG) offers home health care, hospice, neuro-rehabilitation, and pharmacy services.
Why Does BTSG Give Us Pause?
- Expenses have increased as a percentage of revenue over the last two years as its adjusted operating margin fell by 1 percentage points
- Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 4.9 percentage points
- Underwhelming 5.5% return on capital reflects management’s difficulties in finding profitable growth opportunities
At $21.00 per share, BrightSpring Health Services trades at 33.1x forward P/E. Check out our free in-depth research report to learn more about why BTSG doesn’t pass our bar.
One Stock to Buy:
Monolithic Power Systems (MPWR)
Consensus Price Target: $754.60 (20.1% implied return)
Founded in 1997 by its longtime CEO Michael Hsing, Monolithic Power Systems (NASDAQ:MPWR) is an analog and mixed signal chipmaker that specializes in power management chips meant to minimize total energy consumption.
Why Are We Bullish on MPWR?
- Annual revenue growth of 13.1% over the last two years was superb and indicates its market share increased during this cycle
- Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends
- ROIC punches in at 45.7%, illustrating management’s expertise in identifying profitable investments
Monolithic Power Systems’s stock price of $628.38 implies a valuation ratio of 36.6x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.
While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years.
Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like United Rentals (+322% five-year return). Find your next big winner with StockStory today for free.